PhaseRx Inc (PZRXQ)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Robert W. Overell
Employees:
19
410 WEST HARRISON STREET, SUITE 300, SEATTLE, WA 98119
206-805-6300

PhaseRx, Inc. engages in the development of novel RNA-based drugs. The firm RNA therapeutics company developing treatments for orphan liver disease. It is utilizing its proprietary hybrid mRNA delivery system, which offers the ability to deliver messenger RNA therapeutics predictably to selected tissues in vivo, thereby unlocking the value of mRNA as a new therapeutic modality. The company was founded by Robert W. Overell, Patrick S. Stayton, Allan S. Hoffman, Oliver W. Press, and Paul H. Johnson in 2006 and is headquartered in Seattle, WA.

Data derived from most recent annual or quarterly report
Market Cap 11.706 Thousand Shares Outstanding11.706 Million Avg 30-day Volume 12.005 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 0.0 / Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from PZRXQ instead.

View recent insider trading info

Funds Holding PZRXQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PZRXQ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BRANDT GORDON CHIEF MEDICAL OFFICER

  • Officer
0 2017-06-29 0

GILLIS STEVEN

  • Director
  • 10% Owner
0 2017-05-25 0

GRIFFIN MICHELLE RENEE

  • Director
0 2017-05-25 0

JOHNSON PAUL H

  • Director
0 2017-05-25 0

ATWOOD BRIAN G

  • Director
  • 10% Owner
0 2017-05-25 0

PHILLIPS PEGGY V

  • Director
0 2017-05-25 0

SCHMIDT JOHN A JR

  • Director
0 2017-05-25 0

OVERELL ROBERT W PRESIDENT AND CEO

  • Officer
  • Director
0 2016-12-31 0

HOUSTON MICHAEL CHIEF SCIENTIFIC OFFICER

  • Officer
0 2016-12-31 0

TSUI SHING-YIN SENIOR VP, FINANCE, SECRETARY

  • Officer
0 2016-12-31 0

ULEVITCH RICHARD J

  • Director
0 2016-06-01 0

ATWOOD BRIAN G

VERSANT VENTURES III, LLC

VERSANT SIDE FUND III, L.P.

VERSANT VENTURE CAPITAL III, L.P.

COLELLA SAMUEL D

JAFFE ROSS A MD

LINK WILLIAM J PHD

LUBASH BARBARA N

MILDER DONALD B

PRAEGER ROBIN L.

  • Director
  • 10% Owner
1,942,502 2016-05-23 0

ATWOOD BRIAN G

ROBERTSON REBECCA B

WARDEN CHARLES M

BOLZON BRADLEY J PHD

  • Director
  • 10% Owner
1,942,502 2016-05-23 0

GILLIS STEVEN

ARCH VENTURE FUND VII LP

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE PARTNERS VII, LLC

NELSEN ROBERT

BYBEE CLINTON

CRANDELL KEITH

  • Director
  • 10% Owner
4,718,492 2016-05-23 0

ALEXANDRIA REAL ESTATE EQUITIES INC

  • 10% Owner
258,166 2016-05-17 0

ULEVITCH RICHARD J

5AM VENTURES II LP

5AM CO-INVESTORS II LP

5AM PARTNERS II, LLC

SCHWAB ANDREW J.

ROCKLAGE SCOTT M

DIEKMAN JOHN D

  • Director
  • 10% Owner
1,292,299 2016-05-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PHASERX INC PZRXQ 2021-10-26 18:45:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-26 18:15:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-26 17:45:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-26 17:15:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-26 16:45:04 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-26 16:15:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-26 15:45:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-26 15:15:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-26 14:45:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-26 14:15:05 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-26 13:45:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-26 13:15:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-26 12:45:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-25 22:15:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-25 21:45:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-25 21:15:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-25 20:45:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-25 20:15:03 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-25 19:45:04 UTC -1.3226 1.3926 10000
PHASERX INC PZRXQ 2021-10-25 19:15:03 UTC -1.3226 1.3926 10000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments